Oral Health Group
Product Spotlight

DID YOU HEAR? The first and only epinephrine injector with audio instructions!

June 26, 2014
by HANSAmed Ltd.

Introducing Allerject™

Allerject™ is indicated for the emergency treatment of serious allergic reactions (anaphylaxis) and is intended for people who are at risk and for people with a history of serious allergic reactions (anaphylaxis). Allerject™ should be used immediately to treat yourself or your child when experiencing a severe allergic reaction. This is emergency treatment. It does not replace seeing a doctor or going to the hospital. After injection, seek immediate medical attention. Allerject™ contains epinephrine, which is the medication used for the treatment of anaphylaxis.

Allerject™ talks

Research shows that many patients do not know how to correctly use their auto-injector. In studies, only a modest proportion of patients (30–44%) who had been prescribed auto-injectors were able to demonstrate correct self-administration.

Allerject™ has been designed to address these concerns. It is the only epinephrine auto-injector with voice instructions. It guides patients and caregivers step-by-step, calmly and efficiently, through the injection process.

Allerject™ is available with voice instructions in either English or French.

Allerject™ is designed for ease of use

Allerject™ has a number of other features designed to make it easy to use.

  • A light signals when the injection is complete.
  • A retractable needle system. Patients never see the needle – before, during or after injection.
  • A press-and-hold injection method.
  • The automated voice counts down the five seconds of injection time (“5-4-3-2-1, injection complete”), helping patients maintain steady application and confirming drug delivery.

The injector has been designed to be easy-to-use, portable and ergonomic in order to assist patients with complying with recommendations that epinephrine should be available at all times and administered without delay in an allergic emergency.

Request more information

  • This field is for validation purposes and should be left unchanged.

Print this page